FRC
FRC Logo
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us

Resources

  • Videos
  • Research Reports
  • FAQ

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Research
Get Access
Sign In
PainReform Ltd. Stock AnalysisComprehensive stock analysis for PainReform Ltd. (PRFX) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisPRFX
PRFX
PainReform Ltd.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
PRFX
Home🔹Stocks🔹PainReform Ltd.

PainReform Ltd.

PRFX•NASDAQ

PainReform Ltd.

PRFX•NASDAQ
Market cap
$86.17K
Sentiment

Your view on PRFX

Mkt Cap
$86.17K
Sentiment
Your view
PRFX
PainReform Ltd.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
PRFX
Company Overview

Overview

What the company does, where it operates, and who runs it.

About PainReform Ltd.

Industry
Drug Manufacturers - Specialty & Generic
Sector
Healthcare
CEO
Ehud Geller
Headquarters
65 Yigal Alon Street, Tel Aviv, IL
Industry
Drug Manufacturers - Specialty & Generic
Sector
Healthcare
CEO
Ehud Geller
Headquarters
65 Yigal Alon Street, Tel Aviv, IL
Description

PainReform Ltd., a clinical stage specialty pharmaceutical company, engages in the development of therapeutics that provides an extended period of post-surgical pain relief in Israel. It engages in developing PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia. The company is currently conducting two Phase 3 clinical trials of PRF-110 for the treatment of patients undergoing bunionectomy surgery and hernia repair. PainReform Ltd. was incorporated in 2007 and is based in Tel Aviv, Israel.

Infographics

Visual summary of the business at a glance.

FRC Research

Media

Videos and interviews covering the company.

Financial Data

Stock Data

Price chart, volume, and trading data.

Fair Value

What FRC thinks the stock is worth vs. the current price.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

Financial Statements

Income statement, balance sheet, and cash flow statements.

Peer Comparison

Comparables

List of peer companies in the same industry.

Ownership & News

Institutional Ownership

Which funds and firms own the stock.

Insider Trading

Recent buying and selling by company executives.

Senate Trading

U.S. Senator disclosures filed under the STOCK Act.

News

Latest headlines and market coverage.

News

Latest Market News